1. Home
  2. CACI vs CORT Comparison

CACI vs CORT Comparison

Compare CACI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CACI International Inc.

CACI

CACI International Inc.

HOLD

Current Price

$535.97

Market Cap

12.9B

Sector

Technology

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$37.58

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACI
CORT
Founded
1962
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
8.6B
IPO Year
1979
N/A

Fundamental Metrics

Financial Performance
Metric
CACI
CORT
Price
$535.97
$37.58
Analyst Decision
Buy
Buy
Analyst Count
14
6
Target Price
$616.50
$111.00
AVG Volume (30 Days)
249.0K
2.4M
Earning Date
01-21-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
12.06
N/A
EPS
22.62
0.87
Revenue
$8,858,558,000.00
$741,172,000.00
Revenue This Year
$10.72
$23.96
Revenue Next Year
$6.19
$43.40
P/E Ratio
$23.76
$43.73
Revenue Growth
12.61
17.92
52 Week Low
$318.60
$32.99
52 Week High
$632.77
$117.33

Technical Indicators

Market Signals
Indicator
CACI
CORT
Relative Strength Index (RSI) 32.41 17.53
Support Level $538.10 $32.99
Resistance Level $563.00 $85.34
Average True Range (ATR) 11.12 4.07
MACD -3.37 -5.26
Stochastic Oscillator 12.55 8.23

Price Performance

Historical Comparison
CACI
CORT

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: